These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19205557)

  • 21. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
    Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
    Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases].
    De Vita S; D'Ascanio A; Bombardieri S
    Recenti Prog Med; 1991 Nov; 82(11):603-6. PubMed ID: 1763234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
    Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.
    Enk AH; Hadaschik EN; Eming R; Fierlbeck G; French LE; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1657-1669. PubMed ID: 27406069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions.
    Watad A; Amital H; Shoenfeld Y
    Lupus; 2017 Sep; 26(10):1015-1022. PubMed ID: 28420062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
    Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
    Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
    Zandman-Goddard G; Levy Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications for immunoglobulins. Recommendations of CEDIT of AP-HP in 2006].
    Guillevin L
    Rev Med Interne; 2007 May; 28 Spec No. 1():1-3. PubMed ID: 17768830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.
    Sakthiswary R; D'Cruz D
    Medicine (Baltimore); 2014 Oct; 93(16):e86. PubMed ID: 25310743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of intravenous immunoglobulin in the treatment of rheumatic diseases in adults].
    Swierkot J; Lewandowicz-Uszyńska A
    Pol Merkur Lekarski; 2011 Jun; 30(180):435-40. PubMed ID: 21751555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters.
    Cicha A; Fischer MB; Wesinger A; Haas S; Bauer WM; Wolf HM; Sauerwein KMT; Reininger B; Petzelbauer P; Pehamberger H; Handisurya A
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1004-1010. PubMed ID: 29114967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
    Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.
    Steinbrecher A; Berlit P
    J Neurol; 2006 Sep; 253 Suppl 5():V39-49. PubMed ID: 16998753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
    Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.